Liquid chromatographic analysis method for detecting escitalopram content in blood

A technology for blood and water content, applied in measurement devices, analytical materials, material separation, etc., can solve the problems of high cost of liquid chromatography tandem mass spectrometry analysis, unsuitable high-throughput sample detection, and high environmental requirements, so as to shorten the analysis time. time, reducing toxic and side effects, and improving accuracy

Inactive Publication Date: 2018-04-20
BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The analysis cost of liquid chromatography tandem mass spectrometry is very high and has high requirements on the environment
High-performance liquid chromatography is accurate in quantification, good in reproducibility, and good in economic benefits. However, the existing methods still have problems such as complicated pretreatment and long analysis time, and are not suitable for large-throughput sample detection.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid chromatographic analysis method for detecting escitalopram content in blood
  • Liquid chromatographic analysis method for detecting escitalopram content in blood
  • Liquid chromatographic analysis method for detecting escitalopram content in blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037] A method for detecting escitalopram drug concentration in blood, comprising the following steps:

[0038] (1) Calibration of standard solution

[0039] First, mix 20 μL of standard working solution of seven different concentrations with 10 μL of internal standard working solution and 170 μL of complex solution composed of 1:1 methanol and water to make seven standard solutions, and the above standard solutions are vortexed at a speed of 2000 rpm After mixing evenly for 1min, the above-mentioned standard solution is detected using a liquid chromatography analysis instrument and a fluorescence detector, and the escitalopram and the internal standard chromatograms of the above-mentioned seven kinds of standard solutions are obtained, one of which is shown as figure 2As shown, in the above-mentioned escitalopram and internal standard chromatograms, obtain the escitalopram standard target peak area of ​​1 and the cycloheptamide internal standard peak area of ​​2 respectivel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
correlation coefficientaaaaaaaaaa
Login to view more

Abstract

The invention provides a liquid chromatographic analysis method for detecting escitalopram content in blood. The method is characterized in that a standard solution is calibrated through a liquid chromatographic analysis device and a fluorescence detector, and a standard curve equation can be obtained as y=a*x+b by fitting; a blood sample to be detected is prepared and processed and then is detected to obtain y value of the blood to be detected through the liquid chromatographic analysis device and the fluorescence detector; the y value of the blood to be detected is substituted into the standard curve equation, and the relative content x of a target substance in the blood sample to be detected can be calculated; the content of working liquid of an internal standard substance is known, andon that basis, the concentration of escitalopram in the blood to be detected in the sample is calculated. With the adoption of the method, the accuracy of the quantitation result is improved; the system error is avoided; the analyzing time is extremely shortened; the detection process is simple, convenient and quick; experimental foundation is provided for personalized dosing of escitalopram andreducing toxic and side effects of escitalopram.

Description

technical field [0001] The invention relates to the technical field of clinical blood drug concentration monitoring of psychotropic drugs, in particular to a method for detecting the concentration of antidepressant escitalopram in blood. Background technique [0002] The molecular formula of escitalopram is C 20 h 21 FN 2 O, the specific chemical structure is figure 1 As shown, its mechanism of action is to inhibit the reabsorption of 5-hydroxytryptamine and increase the concentration of extracellular 5-hydroxytryptamine in the brain, thereby resisting depression and improving mood. Its relative selectivity is the highest among similar drugs, and it has a strong antidepressant effect. Fewer reactions, better safety and tolerance. [0003] The currently commonly used methods for the determination of escitalopram blood concentration mainly include high performance liquid chromatography-fluorescence detection and liquid chromatography tandem mass spectrometry. The analysi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02
CPCG01N30/02
Inventor 张国成张杰贾永娟倪君君
Owner BEIJING HARMONY HEALTH MEDICAL DIAGNOSTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products